Cas:1236060-59-5 2-Bromo-5-nitro-4-(trifluoromethyl)aniline manufacturer & supplier

Chemical Name:2-Bromo-5-nitro-4-(trifluoromethyl)aniline

CAS.NO:1236060-59-5

Synonyms:2-Bromo-5-nitro-4-(trifluoromethyl)aniline

Molecular Formula:C₇H₄BrF₃N₂O₂

Molecular Weight:285.01800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:71.84000

Exact Mass:283.94100

LogP:4.06270

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Bromo-5-nitro-4-(trifluoromethyl)aniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromo-5-nitro-4-(trifluoromethyl)aniline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Bromo-5-nitro-4-(trifluoromethyl)aniline Use and application,2-Bromo-5-nitro-4-(trifluoromethyl)aniline technical grade,usp/ep/jp grade.

Related News: The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI). 2-Bromo-5-nitro-4-(trifluoromethyl)aniline manufacturer The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development. 2-Bromo-5-nitro-4-(trifluoromethyl)aniline supplier The company memo said Lilly couldn’t substantiate allegations that employees faced retaliation for refusing to make false statements. It did not address employees’ specific complaints that they faced retaliation for other reasons, other than to say it encouraged employees to “speak up.” 2-Bromo-5-nitro-4-(trifluoromethyl)aniline vendor Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration. 2-Bromo-5-nitro-4-(trifluoromethyl)aniline factory The company memo said Lilly couldn’t substantiate allegations that employees faced retaliation for refusing to make false statements. It did not address employees’ specific complaints that they faced retaliation for other reasons, other than to say it encouraged employees to “speak up.”